Recently, a positive association of PCSK9 levels with adverse cardiovascular events has been observed in general population, in patients with familial hypercholesterolemia, in stable CAD, in atrial fibrillation, and in those undergoing PCI [6, 14–17]. This evidence concerns the gene PCSK9 and atrial fibrillation.